share_log

Blueberries Provides Corporate Update, Extends Maturity Date Of Convertible Debentures

Benzinga Real-time News ·  Jul 29, 2022 10:38

Blueberries Medical Corp.(OTCQB:BBRRF) (CSE:BBM) (FRA:1OA)has achieved several CBD and non-psychoactive derivatives shipments to customers in Argentina, and up to date has exported a total of more than 60 kg to 6 different buyers.

Quality validation processes with larger pharmaceutical and cosmetics companies in this country are running positively, and the company estimates annual sales above $2.5 million in 2023. It is also expected that in late Q3 2022, Blueberries initiates the delivery of multiple high THC formulations locally and internationally, starting with Brazil as the first country to export psychoactive formulations. Both Argentina and Brazil are then expected to become the...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment